NCT00650195View on ClinicalTrials.gov

Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

March 31, 2004

Conditions
Healthy
Interventions
DRUG

Metolazone Tablets 10 mg

10mg, single dose fasting

DRUG

Zaroloxyn® Tablets 10 mg

10mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY